Macomics
Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the course of disease
24 employees · est. 2020 · Edinburgh, United Kingdom
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7 axis
38 employees · est. 2020
Side-by-Side Comparison
| Metric | Macomics | NextPoint Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2020 |
| Headquarters | ||
| Headquarters | Edinburgh, United Kingdom | Not tracked yet |
| Employees | ||
| Employees | 24 | 38 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Unknown |
| Total Funding | ||
| Total Funding | $7.44M | $122.48M |
| Funding Rounds | ||
| Funding Rounds | 4 | 2 |
| Services | ||
| Services | developing macrophage-targeting drugs, scientific research in macrophage biology, creating therapies for diseases with unmet medical needs | Drug Development, Precision Medicine, Clinical Trials, Biomarker Identification |
| Target Customers | ||
| Target Customers | pharmaceutical companies, biotechnology firms, medical researchers, healthcare providers seeking novel treatments | Cancer Patients, Oncologists, Healthcare Providers, Biopharmaceutical Researchers |
| Taxonomy | ||
| Taxonomy | Precision Medicines, Macrophage Modulation, Immunotherapy, Cancer Treatment, Tumour-Associated Macrophages, Immune System Modulation, Oncology Therapeutics, TME (Tumor Microenvironment), Immuno-oncology, Drug Development, Immune Defence, First-in-Class Therapies | Precision Therapeutics, Cancer Immunotherapy, B7-H7/HHLA2 Axis, Antibody-Drug Conjugate, Proprietary Linker Technology, T-cell Engager, Checkpoint Inhibitor, Clinical Biomarker, PD-1/L1 Alternative, Adaptive Immune System, Innate Immune System, Tumor-Targeting Modalities, Therapeutic Window, Cancer Biomarker Modulation, Clinical-stage Biotechnology |
| Website | ||
| Website | macomics.com | nextpointtx.com |
About Macomics
Macomics is a pioneering company established in 2020, positioned at the forefront of the Biotechnology and Health and Wellness industries. Headquartered in the United Kingdom, it focuses on a significant niche—developing precision medicines to modulate macrophages for cancer treatment, as highlighte...
About NextPoint Therapeutics, Inc.
NextPoint Therapeutics, Inc., founded in 2020, is at the forefront of innovation in the Biotechnology and Health Care industries. With its slogan, "Launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7 axis", the company positions itself as a pioneer...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Macomics and NextPoint Therapeutics, Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Macomics and NextPoint Therapeutics... — by email.
Frequently Asked Questions
Compare Macomics with someone else
Start typing a company name or domain.